We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$810M
AUM Growth
-$42.6M
Cap. Flow
-$28.5M
Cap. Flow %
-3.51%
Top 10 Hldgs %
24.75%
Holding
329
New
64
Increased
97
Reduced
103
Closed
60

Top Sells

Rank Stock Value
1
GT icon
Goodyear
GT
+$27.9M
2
STJ
St Jude Medical
STJ
+$16.5M
3
AMGN icon
Amgen
AMGN
+$7.53M
4
LGF
Lions Gate Entertainment
LGF
+$7.39M
5
WBD icon
Warner Bros
WBD
+$7.2M

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Technology 15.49%
3 Healthcare 14.33%
4 Consumer Discretionary 13.77%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
251
Pfizer
PFE
$153B
$236K 0.03%
7,404
-93,999
-93% -$3.06M
LUV icon
252
Southwest Airlines
LUV
$23B
$234K 0.03%
+7,076
New +$277K
CWST icon
253
Casella Waste Systems
CWST
$5.69B
$232K 0.03%
41,419
-34,622
-46% -$194K
MCHX icon
254
Marchex
MCHX
$79.7M
$230K 0.03%
+46,535
New +$218K
HWKN icon
255
Hawkins
HWKN
$2.71B
$228K 0.03%
11,304
+3,368
+42% +$68.5K
PLXP
256
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$222K 0.03%
2,178
+683
+46% +$70.7K
GPI icon
257
Group 1 Automotive
GPI
$3.18B
$221K 0.03%
+2,431
New +$208K
XEL icon
258
Xcel Energy
XEL
$48.8B
$219K 0.03%
6,800
CPS icon
259
Cooper-Standard Automotive
CPS
$558M
$213K 0.03%
3,471
+999
+40% +$62.2K
GD icon
260
General Dynamics
GD
$106B
$208K 0.03%
+1,467
New +$204K
SGM
261
DELISTED
Stonegate Mortgage Corporation
SGM
$203K 0.03%
20,142
+5,638
+39% +$59.6K
NNVC icon
262
NanoViricides
NNVC
$36.2M
$195K 0.02%
5,624
+1,615
+40% +$61.5K
ARGS
263
DELISTED
Argos Therapeutics, Inc.
ARGS
$187K 0.02%
1,366
+402
+42% +$64.2K
IL
264
DELISTED
IntraLinks Holdings Inc.
IL
$172K 0.02%
14,452
ACHV icon
265
Achieve Life Sciences
ACHV
$683M
$165K 0.02%
32
+9
+39% +$44.6K
OSUR icon
266
OraSure Technologies
OSUR
$279M
$164K 0.02%
30,475
+8,398
+38% +$51.9K
NAUH
267
DELISTED
National American University Holdings, Inc.
NAUH
$99K 0.01%
34,056
+9,477
+39% +$29.9K
GALT icon
268
Galectin Therapeutics
GALT
$348M
$96K 0.01%
35,299
+9,498
+37% +$28.6K
MBII
269
DELISTED
Marrone Bio Innovations, Inc.
MBII
$32K ﹤0.01%
16,127
+3,354
+26% +$9.51K
ALB icon
270
Albemarle
ALB
$15.5B
-85,667
Closed -$4.53M
AMGN icon
271
Amgen
AMGN
$222B
-47,083
Closed -$7.53M
AON icon
272
Aon
AON
$76B
-35,980
Closed -$3.46M
APA icon
273
APA Corp
APA
$13.2B
-6,005
Closed -$362K
AVNT icon
274
Avient
AVNT
$4.19B
-4,253
Closed -$159K
DCH
275
Dauch Corp
DCH
$1.51B
-8,312
Closed -$215K

Similar funds

Stoneridge Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Stoneridge Investment Partners held 329 positions worth $810M, down 5% from $853M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Stoneridge Investment Partners withdrew a net $28.5M in Q2 2015, closing 60 positions and reducing 103 holdings. Its most notable exit was St Jude Medical, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Stoneridge Investment Partners opened a new position in Applied Materials worth $13.6M.

  • Stoneridge Investment Partners's largest Q2 2015 buy was Applied Materials: 708,212 shares worth $13.6M.
  • Stoneridge Investment Partners added most to Johnson & Johnson in Q2 2015, an estimated $21.6M increase.
  • Stoneridge Investment Partners's biggest Q2 2015 reduction was Goodyear, cutting an estimated $27.9M.
  • Stoneridge Investment Partners fully exited St Jude Medical in Q2 2015, selling an estimated $16.5M.
  • Stoneridge Investment Partners's ten largest holdings make up 25% of its $810M portfolio in Q2 2015.
  • Stoneridge Investment Partners opened 64 new positions and closed 60 in Q2 2015.
  • Stoneridge Investment Partners's portfolio value fell 5% quarter-over-quarter to $810M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2015, filed 29 Jul 2015.